You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

olaparib

Showing 51 - 75 of 230
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Metastatic Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

Recruiting
  • HER2-negative Breast Cancer
  • +2 more
  • Olaparib
  • Barcelona, Spain
  • +4 more
Apr 14, 2022

Prostate Cancer, Prostate Carcinoma, Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Olaparib)

Recruiting
  • Prostate Cancer
  • +2 more
  • Olaparib
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 20, 2022

Epithelial Ovarian Cancer Trial in Mannheim, Essen, Hamburg (olaparib, durvalumab)

Recruiting
  • Epithelial Ovarian Cancer
  • Mannheim, Baden-Württemberg, Germany
  • +2 more
Jun 15, 2022

Advanced Breast Cancer Trial in Spain (Olaparib)

Completed
  • Advanced Breast Cancer
  • Olaparib
  • Badalona, Barcelona, Spain
  • +15 more
Jan 12, 2023

Ovarian Cancer Trial in Naples (Olaparib, Chemotherapy drug)

Recruiting
  • Ovarian Cancer
  • Olaparib
  • Chemotherapy drug
  • Naples, Italy
    IRCCS Istituto Nazionale Tumori di Napoli
Feb 24, 2022

Prostate Trial in United States (Olaparib)

Recruiting
  • Prostate
  • Olaparib
  • Baltimore, Maryland
  • +3 more
Feb 14, 2022

Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

Completed
  • Ovarian Cancer
  • Olaparib
  • +2 more
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 4, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Portland (procedure, drug,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Biopsy
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 29, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • olaparib
  • +3 more
  • Chengdu, China
  • +7 more
Aug 5, 2022

Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
Jul 26, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Biospecimen Collection
  • +2 more
  • Orange, California
  • +9 more
Jan 27, 2023

TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +2 more
  • (no location specified)
Jan 12, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • Olaparib
  • +3 more
  • (no location specified)
Jul 6, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Olaparib
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Small Cell Lung Cancer Trial in Boston (Olaparib, Temozolomide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Jan 24, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United Kingdom, United States (PLX2853, Olaparib, Abiraterone acetate)

Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Chicago, Illinois
  • +7 more
Oct 4, 2022

Glioma, Cholangiocarcinoma, Solid Tumor Trial in Toronto (Olaparib, Durvalumab)

Recruiting
  • Glioma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 29, 2021

Metastatic Castrate Resistant Prostate Cancer, BRCA1, BRCA2, PALB2 Genetic Mutations Trial in United States (Carboplatin,

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • +2 more
  • West Los Angeles, California
  • +13 more
Nov 23, 2022

Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Olaparib
  • +2 more
  • Belfast, County Antrim, United Kingdom
  • +13 more
Feb 22, 2022

Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor Trial

Active, not recruiting
  • Fallopian Tube Endometrioid Tumor
  • +13 more
  • Olaparib
  • Tremelimumab
  • Orange, California
  • +19 more
Jan 10, 2023

Prostate Cancer Trial in United States (Olaparib, Durvalumab)

Active, not recruiting
  • Prostate Cancer
  • Duarte, California
  • +7 more
Mar 30, 2022

Ovarian Cancer Trial in Worldwide (Olaparib, Cediranib)

Recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
  • +53 more
Sep 26, 2022

Pancreatic Cancer Trial (Pembrolizumab, Olaparib)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Oct 21, 2021